LIS-1
- Generic Name
- LIS-1
- Drug Type
- Biotech
- Background
LIS-1 is an immunoglobulin G (IgG) polyclonal antibody that binds to human T cells.
Polyspecific Antibodies in Lymphoproliferative T-cell Disorders
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Xenothera SAS
- Target Recruit Count
- 54
- Registration Number
- NCT06495723
- Locations
- 🇫🇷
CHU de Caen, Caen, France
🇫🇷CHU de Clermont-Ferrand, Clermont-Ferrand, France
🇫🇷CHU Henri-Mondor, Créteil, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath